f A Revolutionary Milestone in Fertility Science: The World's First Fertilo Baby

References

1. Nuñez-CalongeR. SantamariaN. RubioT. Manuel MorenoJ. Making and selecting the best embryo in in vitro fertilization.Arch. Med. Res.202455810306810.1016/j.arcmed.2024.103068 39191078
   [Google Scholar]
2. GunterJ. Blood: The science, medicine, and mythology of menstruation.Citadel2024
   [Google Scholar]
3. DemirerM. KaradumanÖ. Do mergers and acquisitions improve efficiency? evidence from power plants.202410.3386/w32727Available at: https://www.nber.org/papers/w32727
   [Google Scholar]
4. BoschE. LabartaE. KolibianakisE. RosenM. MeldrumD. Regimen of ovarian stimulation affects oocyte and therefore embryo quality.Fertil. Steril.2016105356057010.1016/j.fertnstert.2016.01.022 26826273
   [Google Scholar]
5. CoxirS.A. CostaG.M.J. SantosC.F. AlvarengaR.L.L.S. LacerdaS.M.S.N. From in vivo to in vitro: Exploring the key molecular and cellular aspects of human female gametogenesis.Hum. Cell20233641283131110.1007/s13577‑023‑00921‑7 37237248
   [Google Scholar]
6. NahidS. AlansariL. UmmunnisaF. AmaraU.E. RamireddyN. AlmarzooqiT. Ovarian hyperstimulation syndrome.In: Updates in Intensive Care of OBGY Patients.Springer202418120810.1007/978‑981‑99‑9577‑6_11
   [Google Scholar]
7. GarciaM.B. GarciaP.S. MaaliwR.R. Technoethical Considerations for Advancing Health Literacy and Medical Practice: A Posthumanist Framework in the Age of Healthcare 5.0.In: Emerging Technologies for Health Literacy and Medical Practice.IGI Global202411910.4018/979‑8‑3693‑1214‑8.ch001
   [Google Scholar]
8. DasM. SonW.Y. In vitro maturation (IVM) of human immature oocytes: is it still relevant?Reprod. Biol. Endocrinol.202321111010.1186/s12958‑023‑01162‑x 37993914
   [Google Scholar]
9. GotschelF. SonigoC. BecquartC. SellamiI. MayeurA. GrynbergM. New insights on in vitro maturation of oocytes for fertility preservation.Int. J. Mol. Sci.202425191060510.3390/ijms251910605 39408934
   [Google Scholar]
10. ChatzimeletiouK. PappaK. PetrogiannisN. In vitro maturation of oocytes (IVM): Historical landmarks, current status and future perspectives.Syst Biol Reprod Med202571110211510.1080/19396368.2025.2469574 40073300
    [Google Scholar]
11. AizawaE. PetersA.H. WutzA. In vitro gametogenesis: Towards competent oocytes: Limitations and future improvements for generating oocytes from pluripotent stem cells in culture.BioEssays2025471e240010610.1002/bies.202400106 39498732
    [Google Scholar]
12. LAVANYA K. Serum microRNAs as diagnostic markers in polycystic ovary syndrome: A narrative review.J. Clin. Diagn. Res.2025191BE01BE0610.7860/JCDR/2025/74412.20507
    [Google Scholar]
13. GilchristR.B. SmitzJ. Oocyte in vitro maturation: Physiological basis and application to clinical practice.Fertil. Steril.2023119452453910.1016/j.fertnstert.2023.02.010 36804961
    [Google Scholar]
14. SethiN. AgrawalM. DewaniD. ReddyL.S. DandeA. Navigating fertility challenges: A comprehensive review of microsurgery for fallopian tubal re-canalization in the era of in vitro fertilization (IVF).Cureus20241625495010.7759/cureus.54950 38544594
    [Google Scholar]
15. ParikhN. ChatthaA. FredricksonJ.R. The importance of fertility preservation in the transgender population.Urology2025195919510.1016/j.urology.2024.08.020 39154839
    [Google Scholar]
16. ChitoranE. RotaruV. MitroiuM.N. Navigating fertility preservation options in gynecological cancers: A comprehensive review.Cancers20241612221410.3390/cancers16122214 38927920
    [Google Scholar]
17. AhmadM.F. Mohd NorN.Y. Mohammad RamadnehM.M. Comparative analysis of rescue-in vitro-maturation (r-IVM) outcomes in women with diminished ovarian reserve (DOR) versus normal ovarian reserve (NOR).Biomedicines2025135108410.3390/biomedicines13051084
    [Google Scholar]
18. BraamS. ConstenD. SmeenkJ. In vitro maturation of oocytes in women at risk of ovarian hyperstimulation syndrome—A prospective multicenter cohort study.Int. J. Fertil. Steril.2019131384410.22074/ijfs.2019.5452
    [Google Scholar]
19. ZhuS. JiangW. LiaoX. SunY. ChenX. ZhengB. Effect of diminished ovarian reserve on the outcome of fresh embryo transfer in IVF/ICSI cycles among young women: A retrospective cohort study.BMC Womens Health202424123010.1186/s12905‑024‑03039‑6 38594688
    [Google Scholar]
20. AlviggiC. HumaidanP. FischerR. Patients with low prognosis in ART: A Delphi consensus to identify potential clinical implications and measure the impact of POSEIDON criteria.Reprod. Biol. Endocrinol.202422112210.1186/s12958‑024‑01291‑x 39385174
    [Google Scholar]
21. GernerM. The Vagina Business: The Innovative Breakthroughs that Could Change Everything in Women’s Health.Icon Books2024
    [Google Scholar]
22. PullaB.S. PoteV. DhulkhedkarS. Novel advancements in genome editing technology to be used in in vitro fertilization (IVF).In: Green AI-Powered Intelligent Systems for Disease Prognosis.IGI Global202432134410.4018/979‑8‑3693‑1243‑8.ch017
    [Google Scholar]
23. RashidA.B. KausikM.D.A.K. Ai revolutionizing industries worldwide: A comprehensive overview of its diverse applications.Hybrid Adv2024710027710.1016/j.hybadv.2024.100277
    [Google Scholar]
24. BachmannN. TripathiS. BrunnerM. JodlbauerH. The contribution of data-driven technologies in achieving the sustainable development goals.Sustainability2022145249710.3390/su14052497
    [Google Scholar]